Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease

Abstract This study aimed to identify potential novel drug candidates and targets for Parkinson’s disease. First, 970 genes that have been reported to be related to PD were collected from five databases, and functional enrichment analysis of these genes was conducted to investigate their potential m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pusheng Quan, Kai Wang, Shi Yan, Shirong Wen, Chengqun Wei, Xinyu Zhang, Jingwei Cao, Lifen Yao
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9a7a307920eb490dbf63a8b3f95f2b6e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9a7a307920eb490dbf63a8b3f95f2b6e
record_format dspace
spelling oai:doaj.org-article:9a7a307920eb490dbf63a8b3f95f2b6e2021-12-02T17:44:54ZIntegrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease10.1038/s41598-021-92701-22045-2322https://doaj.org/article/9a7a307920eb490dbf63a8b3f95f2b6e2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92701-2https://doaj.org/toc/2045-2322Abstract This study aimed to identify potential novel drug candidates and targets for Parkinson’s disease. First, 970 genes that have been reported to be related to PD were collected from five databases, and functional enrichment analysis of these genes was conducted to investigate their potential mechanisms. Then, we collected drugs and related targets from DrugBank, narrowed the list by proximity scores and Inverted Gene Set Enrichment analysis of drug targets, and identified potential drug candidates for PD treatment. Finally, we compared the expression distribution of the candidate drug-target genes between the PD group and the control group in the public dataset with the largest sample size (GSE99039) in Gene Expression Omnibus. Ten drugs with an FDR < 0.1 and their corresponding targets were identified. Some target genes of the ten drugs significantly overlapped with PD-related genes or already known therapeutic targets for PD. Nine differentially expressed drug-target genes with p < 0.05 were screened. This work will facilitate further research into the possible efficacy of new drugs for PD and will provide valuable clues for drug design.Pusheng QuanKai WangShi YanShirong WenChengqun WeiXinyu ZhangJingwei CaoLifen YaoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Pusheng Quan
Kai Wang
Shi Yan
Shirong Wen
Chengqun Wei
Xinyu Zhang
Jingwei Cao
Lifen Yao
Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease
description Abstract This study aimed to identify potential novel drug candidates and targets for Parkinson’s disease. First, 970 genes that have been reported to be related to PD were collected from five databases, and functional enrichment analysis of these genes was conducted to investigate their potential mechanisms. Then, we collected drugs and related targets from DrugBank, narrowed the list by proximity scores and Inverted Gene Set Enrichment analysis of drug targets, and identified potential drug candidates for PD treatment. Finally, we compared the expression distribution of the candidate drug-target genes between the PD group and the control group in the public dataset with the largest sample size (GSE99039) in Gene Expression Omnibus. Ten drugs with an FDR < 0.1 and their corresponding targets were identified. Some target genes of the ten drugs significantly overlapped with PD-related genes or already known therapeutic targets for PD. Nine differentially expressed drug-target genes with p < 0.05 were screened. This work will facilitate further research into the possible efficacy of new drugs for PD and will provide valuable clues for drug design.
format article
author Pusheng Quan
Kai Wang
Shi Yan
Shirong Wen
Chengqun Wei
Xinyu Zhang
Jingwei Cao
Lifen Yao
author_facet Pusheng Quan
Kai Wang
Shi Yan
Shirong Wen
Chengqun Wei
Xinyu Zhang
Jingwei Cao
Lifen Yao
author_sort Pusheng Quan
title Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease
title_short Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease
title_full Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease
title_fullStr Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease
title_full_unstemmed Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease
title_sort integrated network analysis identifying potential novel drug candidates and targets for parkinson's disease
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9a7a307920eb490dbf63a8b3f95f2b6e
work_keys_str_mv AT pushengquan integratednetworkanalysisidentifyingpotentialnoveldrugcandidatesandtargetsforparkinsonsdisease
AT kaiwang integratednetworkanalysisidentifyingpotentialnoveldrugcandidatesandtargetsforparkinsonsdisease
AT shiyan integratednetworkanalysisidentifyingpotentialnoveldrugcandidatesandtargetsforparkinsonsdisease
AT shirongwen integratednetworkanalysisidentifyingpotentialnoveldrugcandidatesandtargetsforparkinsonsdisease
AT chengqunwei integratednetworkanalysisidentifyingpotentialnoveldrugcandidatesandtargetsforparkinsonsdisease
AT xinyuzhang integratednetworkanalysisidentifyingpotentialnoveldrugcandidatesandtargetsforparkinsonsdisease
AT jingweicao integratednetworkanalysisidentifyingpotentialnoveldrugcandidatesandtargetsforparkinsonsdisease
AT lifenyao integratednetworkanalysisidentifyingpotentialnoveldrugcandidatesandtargetsforparkinsonsdisease
_version_ 1718379603189301248